{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["(-)-Guaiol", "DSBs", "RAD51", "autophagy", "chemosensitivity"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27566579", "DateCompleted": {"Year": "2018", "Month": "03", "Day": "26"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"ArticleDate": [], "ELocationID": ["10.18632/oncotarget.11540"], "Language": ["eng"], "Journal": {"ISSN": "1949-2553", "JournalIssue": {"Volume": "7", "Issue": "38", "PubDate": {"Year": "2016", "Month": "Sep", "Day": "20"}}, "Title": "Oncotarget", "ISOAbbreviation": "Oncotarget"}, "ArticleTitle": "(-)-Guaiol regulates RAD51 stability via autophagy to induce cell apoptosis in non-small cell lung cancer.", "Pagination": {"StartPage": "62585", "EndPage": "62597", "MedlinePgn": "62585-62597"}, "Abstract": {"AbstractText": ["(-)-Guaiol, generally known as an antibacterial compound, has been found in many medicinal plants. Its roles in tumor suppression are still under investigation. In the study, we mainly focused on exploring its applications in dealing with non-small cell lung cancer (NSCLC) and the underlying mechanisms. Here, we show that (-)-Guaiol significantly inhibits cell growth of NSCLC cells both in vitro and in vivo. Further high throughput analysis reveals that RAD51, a pivotal factor in homologous recombination repair, is a potential target for it. The following mechanism studies show that (-)-Guaiol is involved in cell autophagy to regulate the expression of RAD51, leading to double-strand breaks triggered cell apoptosis. Moreover, targeting RAD51, which is highly overexpressed in the lung adenocarcinoma tissues, can significantly increase the chemosensitivity of NSCLC cells to (-)-Guaiol both in vitro and in vivo. All in all, our studies provide an attractive insight in applying (-)-Guaiol into NSCLC treatments and further suggest that knockdown of oncogenic RAD51 will greatly enhance the chemosensitivity of patients with NSCLC."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Medicine, Tenth People's Hospital of Tongji University, Shanghai, 200072, China."}], "LastName": "Yang", "ForeName": "Qingyuan", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China."}], "LastName": "Wu", "ForeName": "Jianchun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China."}], "LastName": "Luo", "ForeName": "Yingbin", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Medicine, Tenth People's Hospital of Tongji University, Shanghai, 200072, China."}], "LastName": "Huang", "ForeName": "Nan", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Medicine, Tenth People's Hospital of Tongji University, Shanghai, 200072, China."}], "LastName": "Zhen", "ForeName": "Ni", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Medicine, Tenth People's Hospital of Tongji University, Shanghai, 200072, China."}], "LastName": "Zhou", "ForeName": "Yun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Medicine, Tenth People's Hospital of Tongji University, Shanghai, 200072, China."}], "LastName": "Sun", "ForeName": "Fenyong", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Medicine, Yangpu Hospital of Tongji University, Shanghai, 200090, China."}], "LastName": "Li", "ForeName": "Zhi", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Central Laboratory, Tenth People's Hospital of Tongji University, Shanghai, 200072, China."}], "LastName": "Pan", "ForeName": "Qiuhui", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China."}], "LastName": "Li", "ForeName": "Yan", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oncotarget", "NlmUniqueID": "101532965", "ISSNLinking": "1949-2553"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes, Guaiane"}, {"RegistryNumber": "EC 2.7.7.-", "NameOfSubstance": "RAD51 protein, human"}, {"RegistryNumber": "EC 2.7.7.-", "NameOfSubstance": "Rad51 Recombinase"}, {"RegistryNumber": "I7WP008A91", "NameOfSubstance": "guaiol"}], "MeshHeadingList": [{"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Adenocarcinoma"}, {"QualifierName": [], "DescriptorName": "Adenocarcinoma of Lung"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Autophagy"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Carcinoma, Non-Small-Cell Lung"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "DNA Breaks, Double-Stranded"}, {"QualifierName": [], "DescriptorName": "Gene Expression Profiling"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": ["metabolism"], "DescriptorName": "Lysosomes"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": [], "DescriptorName": "Neoplasm Transplantation"}, {"QualifierName": [], "DescriptorName": "Oncogenes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Rad51 Recombinase"}, {"QualifierName": [], "DescriptorName": "Recombination, Genetic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": [], "DescriptorName": "Sesquiterpenes, Guaiane"}], "CoiStatement": "All the authors in the study declare no potential conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Loong HH, Mok K, Leung LK, Mok TS. Crizotinib in the management of advanced-stage non-small-cell lung cancer. Future Oncol. 2015;11:735\u2013745.", "ArticleIdList": ["25757678"]}, {"Citation": "Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, Powell CA, Beer D, Riely G, Garg K, Austin JH, Rusch VW, Hirsch FR, Jett J, Yang PC, Gould M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc. 2011;8:381\u2013385.", "ArticleIdList": ["21926387"]}, {"Citation": "Lim E, Harris G, Patel A, Adachi I, Edmonds L, Song F. Preoperative versus postoperative chemotherapy in patients with resectable non-small cell lung cancer: systematic review and indirect comparison meta-analysis of randomized trials. J Thorac Oncol. 2009;4:1380\u20131388.", "ArticleIdList": ["19861907"]}, {"Citation": "Paul I, Jones JM. Apoptosis block as a barrier to effective therapy in non small cell lung cancer. World J Clin Oncol. 2014;5:588\u2013594.", "ArticleIdList": ["PMC4129524", "25302163"]}, {"Citation": "Horn L. Advances in the treatment of non-small cell lung cancer. J Natl Compr Canc Netw. 2014;12:764\u2013767.", "ArticleIdList": ["24853212"]}, {"Citation": "Song M, Kim SH, Yoon SK. Cabozantinib for the treatment of non-small cell lung cancer with KIF5B-RET fusion. An example of swift repositioning. Arch Pharm Res. 2015;38:2120\u20132123.", "ArticleIdList": ["26377589"]}, {"Citation": "Flemming A. Anticancer drugs: Finding the perfect combination. Nat Rev Drug Discov. 2015;14:13.", "ArticleIdList": ["25549585"]}, {"Citation": "Shu Z, Pu J, Chen L, Zhang Y, Rahman K, Qin L, Zheng C. Alisma orientale: Ethnopharmacology, Phytochemistry and Pharmacology of an Important Traditional Chinese Medicine. Am J Chin Med. 2016;44:227\u2013251.", "ArticleIdList": ["27080939"]}, {"Citation": "Akbulut Y, Gaunt HJ, Muraki K, Ludlow MJ, Amer MS, Bruns A, Vasudev NS, Radtke L, Willot M, Hahn S, Seitz T, Ziegler S, Christmann M, Beech DJ, Waldmann H. (\u2212)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels. Angew Chem Int Ed Engl. 2015;54:3787\u20133791.", "ArticleIdList": ["PMC7116557", "25707820"]}, {"Citation": "Huang AC, Sefton MA, Sumby CJ, Tiekink ER, Taylor DK. Mechanistic studies on the autoxidation of alpha-guaiene: structural diversity of the sesquiterpenoid downstream products. J Nat Prod. 2015;78:131\u2013145.", "ArticleIdList": ["25581486"]}, {"Citation": "Choudhary MI, Batool I, Atif M, Hussain S, Atta Ur R. Microbial transformation of (\u2212)-guaiol and antibacterial activity of its transformed products. J Nat Prod. 2007;70:849\u2013852.", "ArticleIdList": ["17385913"]}, {"Citation": "Park HW, Choi SU, Baek NI, Kim SH, Eun JS, Yang JH, Kim DK. Guaiane sesquiterpenoids from Torilis japonica and their cytotoxic effects on human cancer cell lines. Arch Pharm Res. 2006;29:131\u2013134.", "ArticleIdList": ["16526276"]}, {"Citation": "Ratnayake R, Covell D, Ransom TT, Gustafson KR, Beutler JA. Englerin A a selective inhibitor of renal cancer cell growth from Phyllanthus engleri. Org Lett. 2009;11:57\u201360.", "ArticleIdList": ["PMC2651161", "19061394"]}, {"Citation": "San Filippo J, Sung P, Klein H. Mechanism of eukaryotic homologous recombination. Annu Rev Biochem. 2008;77:229\u2013257.", "ArticleIdList": ["18275380"]}, {"Citation": "Kuo LJ, Yang LX. Gamma-H2AX - a novel biomarker for DNA double-strand breaks. In vivo. 2008;22:305\u2013309.", "ArticleIdList": ["18610740"]}, {"Citation": "Schneider JL, Cuervo AM. Autophagy and human disease: emerging themes. Curr Opin Genet Dev. 2014;26:16\u201323.", "ArticleIdList": ["PMC4253630", "24907664"]}, {"Citation": "Kuma A, Matsui M, Mizushima N. LC3 an autophagosome marker can be incorporated into protein aggregates independent of autophagy: caution in the interpretation of LC3 localization. Autophagy. 2007;3:323\u2013328.", "ArticleIdList": ["17387262"]}, {"Citation": "Liu XX, Sun C, Jin XD, Li P, Zheng XG, Zhao T, Li Q. Genistein sensitizes sarcoma cells in vitro and in vivo by enhancing apoptosis and by inhibiting DSB repair pathways. J Radiat Res. 2016", "ArticleIdList": ["PMC4915536", "26922091"]}, {"Citation": "Qiao GB, Wu YL, Yang XN, Zhong WZ, Xie D, Guan XY, Fischer D, Kolberg HC, Kruger S, Stuerzbecher HW. High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients. Br J Cancer. 2005;93:137\u2013143.", "ArticleIdList": ["PMC2361489", "15956972"]}, {"Citation": "Takenaka T, Yoshino I, Kouso H, Ohba T, Yohena T, Osoegawa A, Shoji F, Maehara Y. Combined evaluation of Rad51 and ERCC1 expressions for sensitivity to platinum agents in non-small cell lung cancer. Int J Cancer. 2007;121:895\u2013900.", "ArticleIdList": ["17417781"]}, {"Citation": "Nogueira A, Assis J, Catarino R, Medeiros R. DNA repair and cytotoxic drugs: the potential role of RAD51 in clinical outcome of non-small-cell lung cancer patients. Pharmacogenomics. 2013;14:689\u2013700.", "ArticleIdList": ["23570471"]}, {"Citation": "Yu SS, Tu Y, Xu LL, Tao XQ, Xu S, Wang SS, Xiong YF, Mei JH. Effects of Rad51 on survival of A549 cells. Asian Pac J Cancer Prev. 2015;16:175\u2013179.", "ArticleIdList": ["25640347"]}, {"Citation": "Gower A, Wang Y, Giaccone G. Oncogenic drivers targeted therapies and acquired resistance in non-small-cell lung cancer. J Mol Med (Berl) 2014;92:697\u2013707.", "ArticleIdList": ["PMC5696571", "24852181"]}, {"Citation": "Bhardwaj B, Revannasiddaiah S, Bhardwaj H, Balusu S, Shwaiki A. Molecular targeted therapy to improve radiotherapeutic outcomes for non-small cell lung carcinoma. Ann Transl Med. 2016;4:50.", "ArticleIdList": ["PMC4740001", "26904572"]}, {"Citation": "McCoach CE, Doebele RC. The minority report: targeting the rare oncogenes in NSCLC. Curr Treat Options Oncol. 2014;15:644\u2013657.", "ArticleIdList": ["PMC4216615", "25228144"]}, {"Citation": "Popelka H, Uversky VN, Klionsky DJ. Identification of Atg3 as an intrinsically disordered polypeptide yields insights into the molecular dynamics of autophagy-related proteins in yeast. Autophagy. 2014;10:1093\u20131104.", "ArticleIdList": ["PMC4091170", "24879155"]}, {"Citation": "Ko JC, Ciou SC, Cheng CM, Wang LH, Hong JH, Jheng MY, Ling ST, Lin YW. Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib IressaR) and chemotherapeutic agents in human lung cancer cells. Carcinogenesis. 2008;29:1448\u20131458.", "ArticleIdList": ["18544565"]}, {"Citation": "Richardson C. RAD51 genomic stability and tumorigenesis. Cancer Lett. 2005;218:127\u2013139.", "ArticleIdList": ["15670890"]}, {"Citation": "Li GY, Fan B, Su GF. Acute energy reduction induces caspase-dependent apoptosis and activates p53 in retinal ganglion cells (RGC-5) Exp Eye Res. 2009;89:581\u2013589.", "ArticleIdList": ["19524568"]}, {"Citation": "Adamiec-Mroczek J, Zajac-Pytrus H, Misiuk-Hojlo M. Caspase-Dependent Apoptosis of Retinal Ganglion Cells During the Development of Diabetic Retinopathy. Adv Clin Exp Med. 2015;24:531\u2013535.", "ArticleIdList": ["26467145"]}, {"Citation": "Ko JC, Tsai MS, Weng SH, Kuo YH, Chiu YF, Lin YW. Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells. Toxicol Appl Pharmacol. 2011;255:327\u2013338.", "ArticleIdList": ["21810436"]}, {"Citation": "Chen RS, Jhan JY, Su YJ, Lee WT, Cheng CM, Ciou SC, Lin ST, Chuang SM, Ko JC, Lin YW. Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation. Exp Cell Res. 2009;315:2658\u20132672.", "ArticleIdList": ["19505457"]}, {"Citation": "Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 1998;8:397\u2013403.", "ArticleIdList": ["9789328"]}, {"Citation": "Yang Q, Pan Q, Li C, Xu Y, Wen C, Sun F. NRAGE is involved in homologous recombination repair to resist the DNA-damaging chemotherapy and composes a ternary complex with RNF8-BARD1 to promote cell survival in squamous esophageal tumorigenesis. Cell Death Differ. 2016", "ArticleIdList": ["PMC4947671", "27035619"]}, {"Citation": "Zhen N, Yang Q, Wu Q, Zhu X, Wang Y, Sun F, Mei W, Yu Y. A novelly synthesized phenanthroline derivative is a promising DNA-damaging anticancer agent inhibiting G1/S checkpoint transition and inducing cell apoptosis in cancer cells. Cancer Chemother Pharmacol. 2016;77:169\u2013180.", "ArticleIdList": ["26590990"]}, {"Citation": "Yang Q, Wang R, Xiao W, Sun F, Yuan H, Pan Q. Cellular Retinoic Acid Binding Protein 2 Is Strikingly Downregulated in Human Esophageal Squamous Cell Carcinoma and Functions as a Tumor Suppressor. PLoS One. 2016;11:e0148381.", "ArticleIdList": ["PMC4739712", "26839961"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "4", "Day": "26"}, {"Year": "2016", "Month": "8", "Day": "11"}, {"Year": "2016", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "9", "Day": "20"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27566579", "PMC5308748", "10.18632/oncotarget.11540", "11540"]}}], "PubmedBookArticle": []}